SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-021582
Filing Date
2022-11-03
Accepted
2022-11-03 08:35:01
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cinc-20220930.htm   iXBRL 10-Q 2426522
2 EX-31.1 cinc-ex31_1.htm EX-31.1 19657
3 EX-31.2 cinc-ex31_2.htm EX-31.2 19710
4 EX-32.1 cinc-ex32_1.htm EX-32.1 23677
  Complete submission text file 0000950170-22-021582.txt   7752564

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cinc-20220930.xsd EX-101.SCH 45275
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cinc-20220930_cal.xml EX-101.CAL 32323
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cinc-20220930_pre.xml EX-101.PRE 297187
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cinc-20220930_lab.xml EX-101.LAB 410590
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cinc-20220930_def.xml EX-101.DEF 184554
49 EXTRACTED XBRL INSTANCE DOCUMENT cinc-20220930_htm.xml XML 1345546
Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Filer) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41201 | Film No.: 221356402
SIC: 2834 Pharmaceutical Preparations